Human Senescence Atlas: Where Zombie Cells Are Found in the Body

2026 SenNet research

The Human Senescence Atlas is helping researchers map where different types of senescent, or “zombie,” cells occur in the human body. Emerging SenNet research shows that cellular senescence is heterogeneous, with different senescent-cell states appearing across tissues and biological contexts.

In 2026, researchers from the NIH-funded Cellular Senescence Network, known as SenNet, published major new work aimed at identifying where senescent cells are found, how they differ, and how those differences change across tissues and over the lifespan.

The work represents an important shift in cellular-senescence research. Instead of simply asking whether senescent cells accumulate with age, scientists are increasingly asking a more precise set of questions:

• Which cells become senescent?
• Where in the body are they found?
• How do they differ from one tissue to another?
• Which senescent cells may be harmful?
• Which may still serve useful biological functions?

If you are new to this topic, start with our guide to what zombie cells are and how cellular senescence works.

What is the Human Senescence Atlas?

The Cellular Senescence Network was launched by the National Institutes of Health to identify and characterize senescent cells across the human body, across different states of health, and across the lifespan.

Senescent cells are cells that have stopped dividing but remain biologically active. They can develop after stress or damage and may release signaling molecules that affect surrounding tissue.

They are also relatively rare and difficult to identify. There is no single universal marker that reliably identifies every senescent cell in every tissue.

That is one reason the SenNet project is important. Researchers are combining single-cell analysis, spatial biology, imaging, transcriptomics, proteomics, and computational methods to build a more detailed map of cellular senescence.

A new idea: “senotypes”

One of the major concepts emerging from the 2026 work is the idea of different senotypes.

Rather than treating all senescent cells as biologically identical, researchers are classifying them according to characteristics such as tissue location, cell type, surrounding environment, health status, and molecular behavior.

This matters because a senescent immune cell may not behave the same way as a senescent kidney cell, fat cell, lung cell, or brain-associated cell.

The new framework therefore suggests that cellular senescence should be understood as a collection of different biological states rather than one single condition.

Where have researchers found senescent cells?

SenNet researchers are mapping senescence across multiple human tissues and organs.

Recent work has included tissues from areas such as the brain prefrontal cortex, lungs, lymph nodes, skin, kidney-related systems, adipose tissue, and immune tissues.

The SenNet data portal now contains large numbers of datasets spanning many organs and multiple forms of molecular and spatial analysis.

This does not mean every senescent cell in the human body has been mapped. The atlas is an evolving research resource rather than a finished anatomical map.

What researchers found in human lymph nodes

One 2026 study examined human lymph nodes from donors ranging from young adulthood into advanced age.

Researchers observed age-related changes in the location and characteristics of senescent cells. In older lymph nodes, clusters of senescent B cells were identified alongside signs of altered metabolism and impaired antibody-related function.

These findings may help researchers understand how cellular senescence contributes to age-related changes in immune function.

However, this type of research identifies biological associations and patterns. It does not establish that removing those cells would automatically restore youthful immune function.

Why biomarkers matter

A major challenge in senescence research is that there is no single marker that identifies every senescent cell with complete reliability.

Researchers therefore use combinations of markers and molecular features rather than relying on one signal alone. The 2026 SenNet work is helping refine these combinations and connect them to specific tissues and cell types.

This is important because better biomarkers could eventually help scientists measure senescent-cell burden more accurately and determine whether an experimental senolytic intervention is affecting the intended cells.

Why this complicates the idea of a single senolytic

The growing evidence for multiple senotypes raises an important question for senolytic research: if senescent cells differ substantially across tissues, will one compound affect all of them equally?

Probably not.

Different senescent cells may depend on different survival pathways and produce different signaling patterns. That means an intervention that affects one senescent-cell population may have little effect on another.

This is one reason researchers are increasingly interested in more targeted approaches rather than assuming that all senescent cells can be treated as one uniform category.

For an introduction to this field, see our guide to what senolytics are and how researchers think they work.

Not all senescent cells are harmful

The atlas also reinforces an important point: senescence is not automatically harmful.

Senescent cells can play useful roles in processes such as wound healing, development, tissue remodeling, and tumor suppression. Problems may arise when certain senescent cells persist, accumulate, or produce chronic inflammatory signaling.

This is why the scientific goal is not simply to “remove every zombie cell.” Researchers are trying to understand which senescent cells are harmful, which are beneficial, and when intervention might make sense.

For more on that distinction, read Can Senescent Cells Be Helpful?

How this changes the aging conversation

For years, the public discussion around cellular senescence has often been simplified into a single idea: zombie cells increase with age and therefore should be eliminated.

The newer human-mapping work suggests a more nuanced picture.

Senescent cells appear to differ by organ, cell type, molecular profile, and biological context. Some may contribute to tissue dysfunction, while others may serve short-term protective or repair functions.

That means the most important questions are becoming more specific:

• Which senotypes are associated with particular age-related problems?
• Which markers best identify those cells?
• Which interventions target those specific senotypes?
• Can harmful populations be reduced without disrupting beneficial senescence?

What the Human Senescence Atlas does not prove

The atlas is a major scientific resource, but it does not prove that senolytic supplements slow human aging.

It also does not establish that removing senescent cells throughout the body is safe, desirable, or achievable with currently available supplements.

The research is primarily helping scientists identify and characterize senescent cells more accurately so that future studies can test targeted interventions with better biological precision.

The takeaway

The Human Senescence Atlas is changing the way researchers think about zombie cells.

Rather than viewing cellular senescence as one uniform state, scientists are mapping a diverse collection of senotypes across human tissues. That complexity may help explain why senescence can sometimes be beneficial, sometimes harmful, and difficult to target with a single intervention.

The most important development is not that researchers have found a universal anti-aging target. It is that they are building a more detailed map of where senescent cells exist and how they behave.

That map may eventually help researchers design more precise senolytic strategies — but that work is still developing.

Read the source material

• NIH — New framework for the role of senescence in aging
• NIH Common Fund — Cellular Senescence Network (SenNet)
• SenNet Data Portal
• Do Zombie Cells Increase With Age?
• SASP Explained

Educational information only. This article discusses emerging research on cellular senescence and aging. It is not medical advice and should not be interpreted as a recommendation to use senolytic drugs or supplements.